Literature DB >> 8211875

Phospholipid content of bronchoalveolar lavage fluid in granite workers with silicosis in Quebec.

R Bégin1, O Lesur, T Bouhadiba, L Guojian, P Larivée, B Melloni, M Martel, A Cantin.   

Abstract

BACKGROUND: Some of the prominent features of silicosis are hyperplasia and hypertrophy of epithelial type II cells, which in experimental animals are often accompanied by accumulation of phospholipids in the lung.
METHODS: The total phospholipid content of lung lavage fluid and its composition in 28 granite stone cutters with long term exposure to silica dust (23 with radiological silicosis) was compared with that of lavage fluid in 15 normal volunteers, 15 patients with untreated idiopathic pulmonary fibrosis, and 19 patients with untreated stage 2 or 3 sarcoidosis. All lavage fluid was obtained at the time of first pulmonary investigation, which also included lung function tests.
RESULTS: In the normal subjects total phospholipid content was 1.13 (0.16) micrograms phosphorus/ml of lung lavage, in the patients with idiopathic pulmonary fibrosis 0.52 (0.07) microgram/ml (p < 0.05), and in the patients with sarcoidosis 1.02 (0.20) microgram/ml composition being in the range reported in humans. In the patients with silicosis total phospholipid content was significantly decreased to an average of 0.46 (0.08) microgram/ml compared with the findings in normal subjects and patients with sarcoidosis. Within the group exposed to silica changes in total phospholipid content did not correlate with the severity of the radiographic disease, changes in lung function, the cellularity of lung lavage fluid, or hyaluronate concentrations. The secretory capacity of rat epithelial type II cells was not significantly different when cultured with bronchoalveolar lavage fluid from all four groups of subjects.
CONCLUSIONS: Total phospholipid content in lung lavage fluid was significantly reduced in granite workers with radiological evidence of lung disease, but showed no correlation with radiological or functional markers of disease severity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8211875      PMCID: PMC464719          DOI: 10.1136/thx.48.8.840

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  26 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots.

Authors:  G Rouser; S Fkeischer; A Yamamoto
Journal:  Lipids       Date:  1970-05       Impact factor: 1.880

3.  Deposition and translocation of inhaled silica in rats. Quantification of particle distribution, macrophage participation, and function.

Authors:  A R Brody; M W Roe; J N Evans; G S Davis
Journal:  Lab Invest       Date:  1982-12       Impact factor: 5.662

4.  Inhibition of surfactant release from isolated Type II cells by compound 48/80.

Authors:  W R Rice; J A Whitsett
Journal:  Biochim Biophys Acta       Date:  1984-11-13

5.  Mineral dust and cell recovery from the bronchoalveolar lavage of healthy Vermont granite workers.

Authors:  J W Christman; R J Emerson; W G Graham; G S Davis
Journal:  Am Rev Respir Dis       Date:  1985-08

6.  Bronchoalveolar lavage in silicosis. Evidence of type II cell hyperplasia.

Authors:  M R Schuyler; H R Gaumer; R P Stankus; J Kaimal; E Hoffmann; J E Salvaggio
Journal:  Lung       Date:  1980       Impact factor: 2.584

7.  Determination of hyaluronate in biological samples by a specific radioassay technique.

Authors:  U B Laurent; A Tengblad
Journal:  Anal Biochem       Date:  1980-12       Impact factor: 3.365

8.  Heterogeneity of bronchoalveolar lavage cellularity in stage III pulmonary sarcoidosis.

Authors:  A Cantin; R Bégin; M Rola-Pleszczynski; R Boileau
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

9.  Circulating immune complexes in the idiopathic interstitial pneumonias.

Authors:  R B Dreisin; M I Schwarz; A N Theofilopoulos; R E Stanford
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

10.  Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol.

Authors:  M Hallman; R Spragg; J H Harrell; K M Moser; L Gluck
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

View more
  1 in total

1.  Alterations of surfactant lipid turnover in silicosis: evidence of a role for surfactant-associated protein A (SP-A).

Authors:  O Lesur; T Bouhadiba; B Melloni; A Cantin; J A Whitsett; R Bégin
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.